KAWASAKI, Japan–(BUSINESS WIRE)–Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has launched “DF2B6M4BSL,” an ultra-low capacitance…
With the first production-intent FF 91, Faraday Future has marked manufacturing Milestone #4 and remains…
BAT’s Simon Ashton Appointed to the Board of Directors MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc….
NEW YORK–(BUSINESS WIRE)–#C3–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is…
NEW YORK–(BUSINESS WIRE)–International Seaways, Inc. (NYSE: INSW) (the “Company” or “INSW”) announced today that it…
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
Affirms the advancements of innovative biosimulation technology and its growing impact in R&D PRINCETON, N.J.,…
Analysis shows combinatorial approach is more effective than single-gene testing at predicting sertraline metabolism in patients…
Reports Full-Year Net Revenue of $10.4 Million, a 22% Year-Over-Year Increase and Fourth Quarter Net Revenue…
Achieved Oxbryta® (voxelotor) net revenues of $56.1 million in the fourth quarter and $194.7 million…
— Company Expects to Announce Topline Results from the Phase 1/2 Study by the End of…
Orphazyme A/SCompany announcementNo. 07/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 23, 2022 – Orphazyme…
2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE)…
Markham, Ontario–(Newsfile Corp. – February 23, 2022) – Mary Agrotechnologies Inc. (CSE: MARY) (OTCQB: MRRYF)…
AUSTIN, Texas–(BUSINESS WIRE)–Hyliion Holdings Corp. (NYSE: HYLN) (“Hyliion”), a leader in electrified powertrain solutions for…
FRANKFURT, Germany–(BUSINESS WIRE)–MV Index Solutions GmbH (MVIS®) today announced the results of the monthly MVIS…
Filing of the 2021 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual…
AlloCAR T™ Studies Resumed and Currently Enrolling Patients Following Removal of Clinical Hold in January…
MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced…
Represents 6th Consecutive Year of Over 20% Revenue Growth; Annual Revenue Surpasses $1 Billion Omnipod…